Analyst Research

Report Title Price
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: GlobalData
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

NeuroSearch A/S Closes Sale of Huntexil to Teva Pharmaceutical Industries Ltd; Raises FY 2012 Guidance

Thursday, 25 Oct 2012 05:04am EDT 

NeuroSearch A/S announced that the Company has closed the asset transfer agreement with Teva Pharmaceutical Industries Ltd. concerning the sale of the Huntexil project as described in announcement no. 21-12 of September 27, 2012. The agreement was approved by the Company's shareholders at the Extraordinary General Meeting, which was held on October 23, 2012. In addition, the Company has adjusted the expectations and now expects to report an operating loss of approximately DKK 350 million in the fiscal year 2012 against a previously expected operating loss of DKK 465 million. 

Company Quote

0.01 +0.29%
11 Jul 2014